Cerebral activator

A cerebral activator, or cerebral metabolic enhancer, is a type of drug that "activates" the central nervous system in the context of cerebrovascular diseases such as stroke and dementia. The term has been used specifically to describe a few Japanese drugs, such as indeloxazine and bifemelane.[1][2][3]

References
  1. Yamamoto, M; Kawabata, S; Shimizu, M (1989). "Pharmacological effects of indeloxazine, a new cerebral activator, on brain functions distinct from other cerebral metabolic enhancers". Neuropharmacology. 28 (12): 1291–1297. doi:10.1016/0028-3908(89)90001-4. ISSN 0028-3908.
  2. Takahashi, Koichiro; Yamamoto, Minoru; Suzuki, Masanori; Ozawa, Yukiko; Yamaguchi, Takashi; Andoh, Hirofumi; Ishikawa, Kouichi (1995). "Effects of cerebral metabolic enhancers on brain function in rodents". Current Therapeutic Research. 56 (5): 478–485. doi:10.1016/0011-393X(95)85080-5. ISSN 0011-393X.
  3. van Reekum R, Black SE, Conn D, Clarke D (1997). "Cognition-enhancing drugs in dementia: a guide to the near future". Can J Psychiatry. 42 Suppl 1: 35S–50S. PMID 9220128.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.